Four-dimensional positron emission tomography: Implications for dose painting of high-uptake regions

International Journal of Radiation Oncology Biology Physics

Volumn 80, Issue 3, 2011, Pages 900-908

  Aristophanous, Michalis ^a   Yap, Jeffrey T ^b   Killoran, Joseph H ^a   Chen, Aileen B ^a   Berbeco, Ross I ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

4D PET CT; Biological target volume; Dose painting; Lung cancer

Indexed keywords

4D PET/CT; BIOLOGICAL TARGETS; CLASSIFICATION ALGORITHM; COMPLEX RELATIONSHIPS; DOSE PAINTING; EMISSION TOMOGRAPHY; FDG-PET; FLUORODEOXYGLUCOSE; INTERNAL TARGET VOLUME; LUNG CANCER; LYMPH NODE; PET SCAN; SHAPE DEFORMATION; STATISTICALLY SIGNIFICANT DIFFERENCE; SUBVOLUMES; TARGET VOLUMES; TUMOR VOLUMES;

BEHAVIORAL RESEARCH; BIOLOGICAL MATERIALS; DEFORMATION; POSITRONS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

FLUORODEOXYGLUCOSE F 18;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; LYMPH NODE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ALGORITHMS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN;

EID: 79957563117     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.08.028     Document Type: Article

References (22)

1. S. Senan, and D. De Ruysscher Critical review of PET-CT for radiotherapy planning in lung cancer Crit Rev Oncol Hematol 56 2005 345 351 (Pubitemid 41677616)
2. C. Greco, K. Rosenzweig, and G.L. Cascini Current status of PET/CT for tumour volume definition in radiotherapy treatment planning for non-small cell lung cancer (NSCLC) Lung Cancer 57 2007 125 134 (Pubitemid 47043188)
3. U. Nestle, K. Walter, and S. Schmidt 18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: high impact in patients with atelectasis Int J Radiat Oncol Biol Phys 44 1999 593 597 (Pubitemid 29258434)
4. Y.E. Erdi, K. Rosenzweig, and A.K. Erdi Radiotherapy treatment planning for patients with non-small cell lung cancer using positron emission tomography (PET) Radiother Oncol 62 2002 51 60 (Pubitemid 34121949)
5. J. Bradley, W.L. Thorstad, and S. Mutic Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer Int J Radiat Oncol Biol Phys 59 2004 78 86 (Pubitemid 38501510)
6. E.J. Hall Radiobiology for the radiologist 5th ed. 2000 Lippincott Williams & Wilkins Philadelphia
7. M. Alber, F. Paulsen, and S.M. Eschmann On biologically conformal boost dose optimization Phys Med Biol 48 2003 N31 N35
8. S.K. Das, M.M. Miften, and S. Zhou Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions Med Phys 31 2004 1452 1461 (Pubitemid 38808513)
9. K.S. Chao, W.R. Bosch, and S. Mutic A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 49 2001 1171 1182 (Pubitemid 32184623)
10. C.C. Ling, J. Humm, and S. Larson Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality Int J Radiat Oncol Biol Phys 47 2000 551 560 (Pubitemid 30317470)
11. A. Søvik, E. Malinen, and D.R. Olsen Strategies for biologic image-guided dose escalation: A review Int J Radiat Oncol Biol Phys 73 2009 650 658
12. Y. Ichiya, Y. Kuwabara, and M. Sasaki A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma Ann Nucl Med 10 1996 193 200 (Pubitemid 26197405)
13. S.M. Eschmann, G. Friedel, and F. Paulsen Is standardised (18)F-FDG uptake value an outcome predictor in patients with stage III non-small cell lung cancer? Eur J Nucl Med Mol Imaging 33 2006 263 269
14. H.J. Aerts, A.A. van Baardwijk, and S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
15. A. Abramyuk, S. Tokalov, and K. Zöphel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
16. S.J. Park, D. Ionascu, and J. Killoran Evaluation of the combined effects of target size, respiratory motion and background activity on 3D and 4D PET/CT images Phys Med Biol 53 2008 3661 3679 (Pubitemid 352020047)
17. M. Aristophanous, A.B. Chen, and J. Yap PET-guided dose painting for moving tumors of the lung: A preliminary analysis contrasting 3D and 4D scans (Abstr.) Radiother Oncol 94S1 2010 S12
18. M. Hudson, and R. Larkin Accelerated image reconstruction using ordered subsets of projection data IEEE Trans Med Imaging 13 1994 601 609
19. M. Aristophanous, B.C. Penney, and M.K. Martel A Gaussian mixture model for definition of lung tumor volumes in positron emission tomography Med Phys 34 2007 4223 4235 (Pubitemid 350029644)
20. Y. Yang, Y. Wu, and J. Qi A prototype PET scanner with DOI-encoding detectors J Nucl Med 49 2008 1132 1140 (Pubitemid 351948022)
21. A.J. Reader The promise of new PET image reconstruction Phys Med 24 2008 49 56
22. J.S. Karp, S. Surti, and M.E. Daube-Witherspoon Benefit of time-of-flight in PET: Experimental and clinical results J Nucl Med 49 2008 462 470 (Pubitemid 351355213)